SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015527
Filing Date
2018-11-09
Accepted
2018-11-09 08:01:35
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 861041
2 ex31-1.htm EX-31.1 18729
3 ex31-2.htm EX-31.2 18782
4 ex32-1.htm EX-32.1 6493
5 ex32-2.htm EX-32.2 6568
  Complete submission text file 0001493152-18-015527.txt   3261937

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vbiv-20180930.xml EX-101.INS 465869
7 XBRL SCHEMA FILE vbiv-20180930.xsd EX-101.SCH 50175
8 XBRL CALCULATION FILE vbiv-20180930_cal.xml EX-101.CAL 58113
9 XBRL DEFINITION FILE vbiv-20180930_def.xml EX-101.DEF 119684
10 XBRL LABEL FILE vbiv-20180930_lab.xml EX-101.LAB 284229
11 XBRL PRESENTATION FILE vbiv-20180930_pre.xml EX-101.PRE 200084
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 181171422
SIC: 2834 Pharmaceutical Preparations